Telo Genomics Corp.: Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced telomere ...
ascopubs.org

D3Oncoprint: Stand-Alone Software to Visualize and Dynamically Explore Annotated Genomic Mutation Files

CAFE MOCHA: An Integrated Platform for Discovering Clinically Relevant Molecular Changes in Cancer—An Example of Distant Metastasis– and Recurrence-Linked Classifiers in Head and Neck Squamous Cell ...
Morningstar

NomosLogic Introduces Molecular Medicine Infrastructure for Consumer Genomics, Multi-Omic Fusion, and Deterministic Disease Modeling

NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease ...
Morningstar

IndyGeneUS Bio Files Patent for Clinico-Genomic Insight Engine™, Advancing their AI×Bio Factory Hub from Baltimore to Africa

BALTIMORE, Jan. 12, 2026 /PRNewswire/ -- IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ (CGIE™)—a foundational platform under ...
Nasdaq

IP Strategy Highlights GenoBank’s Expansion of Onchain Genomic Data on Story

GIG HARBOR, Wash., March 27, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company”) today highlighted recent progress from GenoBank.io, a Story ecosystem project bringing ...

Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced telomere analytics, today announced that it has filed a U.S ...